Találati lista | Tudóstér

001-es BibID:	BIBFORM113608
035-os BibID:	(cikkazonosító)711 (scopus)85153749710 (wos)000978970200001
Első szerző:	Dohos Dóra
Cím:	Hungarian Linguistic, Cross-Cultural and Age Adaptation of Transition Specific Questionnaires in Patients with Inflammatory Bowel Disease / Dohos Dóra, Váradi Alex, Farkas Nelli, Erős Adrienn, Müller Katalin Eszter, Karoliny Anna, Gombos Eszter, Nemes Éva, Vass Noémi, Tárnok András, Hegyi Péter, Sarlós Patrícia
Dátum:	2023
ISSN:	2227-9067
Megjegyzések:	Objective: In the TRANS?IBD clinical trial, the outcomes are measured with selected validated questionnaires. Cross-cultural and age adaptations of the Self-Efficacy Scale for adolescents and young adults (IBD?SES), the Transition Readiness Assessment Questionnaire (TRAQ), and the Self Management and Transition Readiness Questionnaire (STARx) were performed. Methods: Linguistic and cultural adaptation was carried out with the usage of reliability coefficients (Cronbach's ? coefficients, Spearman's rank correlation), and with confirmatory factor analysis (CFA; root Mean Square Error of Approximation [RMSEA], Comparative Fit Index [CFI], and Tucker-Lewis Index [TLI]). Results: 112 adolescents participated in the study (45.5% male, mean age 17 ? 1.98 years ). CFA was acceptable in the IBD?SES and the TRAQ. Internal consistency was acceptable in IBD? SES and good in TRAQ (0.729; 0.865, respectively). Test?retest reliability was good in IBD?SES, but below the acceptable threshold in TRAQ (? = 0.819; ? = 0.034). In STARx tools, RMSEA showed poor fit values, CFI and TLI were below acceptable fit values, and internal consistency was not satisfied (0.415; 0.693, respectively), while test?retest reliabilities were acceptable (? = 0.787; ? = 0.788, respectively). Conclusions: Cross-cultural, age-specific adaptation was successfully completed with IBD?SES and TRAQ. Those are comparable to the original validated versions. The adaption of the STARx tools was not successful.
Tárgyszavak:	Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban folyóiratcikk
Megjelenés:	Children. - 10 : 4 (2023), p. 1-14. -
További szerzők:	Váradi Alex (1991-) (biológus) Farkas Nelli Erős Adrienn Müller Katalin Eszter Karoliny Anna Gombos Eszter (1963-) (történelem, német, filozófia, informatika szakos pedagógus) Nemes Éva (1957-) (csecsemő- és gyermekgyógyász, gasztroenterológus) Vass Noémi Tárnok András Hegyi Péter Jr. (belgyógyász) Sarlós Patrícia
Internet cím:	Szerző által megadott URL DOI Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon:

001-es BibID:	BIBFORM105425
035-os BibID:	(scopus)85139358640
Első szerző:	Dohos Dóra
Cím:	Inflammatory bowel disease does not alter the clinical features and the management of acute pancreatitis : A prospective, multicentre, exact-matched cohort analysis / Dora Dohos, Nelli Farkas, Alex Varadi, Balint Erőss, Andrea Parniczky, Andrea Szentesi, Peter Hegyi, Patrícia Sarlos, Hungarian Pancreatic Study Group
Dátum:	2022
ISSN:	1424-3903
Megjegyzések:	Objective and aims: Acute pancreatitis in inflammatory bowel disease occurs mainly as an extraintestinal manifestation or a side effect of medications. We aimed to investigate the prognostic factors and severity indicators of acute pancreatitis and the treatment of patients with both diseases. Design: We performed a matched case-control registry analysis of a multicentre, prospective, interna tional acute pancreatitis registry. Patients with both diseases were matched to patients with acute pancreatitis only in a 1:3 ratio by age and gender. Subgroup analyses were also carried out based on disease type, activity, and treatment of inflammatory bowel disease. Results: No difference in prognostic factors (laboratory parameters, bedside index of severity in acute pancreatitis, imaging results) and outcomes of acute pancreatitis (length of hospitalization, severity, and local or systemic complications) were detected between groups. Significantly lower analgesic use was observed in the inflammatory bowel disease population. Antibiotic use during acute pancreatitis was significantly more common in the immunosuppressed group than in the non-immunosuppressed group (p ? 0.017). However, none of the prognostic parameters or the severity indicators showed a significant difference between any subgroup of patients with inflammatory bowel disease. Conclusion: No significant differences in the prognosis and severity of acute pancreatitis could be detected between patients with both diseases and with pancreatitis only. The need for different acute pancreatitis management is not justified in the coexistence of inflammatory bowel disease, and antibiotic overuse should be avoided. ? 2022 The Authors. Published by Elsevier B.V. on behalf of IAP and EPC. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
Tárgyszavak:	Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban folyóiratcikk
Megjelenés:	Pancreatology. - 22 : 8 (2022), p. 1071-1078. -
További szerzők:	Farkas Nelli Váradi Alex (1991-) (biológus) Erőss Bálint Párniczky Andrea (gyermekgyógyász) Szentesi Andrea Hegyi Péter Jr. (belgyógyász) Sarlós Patrícia Papp Mária (1975-) (belgyógyász, gasztroenterológus) Hungarian Pancreatic Study Group
Pályázati támogatás:	ÚNKP-21-5-PTE-1341 Egyéb FK 132834 Egyéb FK 138929 Egyéb ÚNKP-21-5 Egyéb
Internet cím:	DOI Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon: